AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Dino Polska S.A.

M&A Activity Apr 3, 2024

5587_rns_2024-04-03_850687da-804f-48e6-b123-168506075774.html

M&A Activity

Open in Viewer

Opens in native device viewer

Report Content Current Report no. 5/2024 - Acquisition by DINO POLSKA S.A. of an equitystake in the internet drugstore eZebra.pl sp. z o.o.

In reference to current report no. 8/2023 concerning the conclusion ofthe Preliminary Conditional Agreement for the Sale of Shares and theShareholder Agreement ("Agreement") with the company doing business aseZebra.pl sp. z o.o. with its registered office in Lublin ("eZebra") andits shareholders ("Founders"), the Management Board of DINO POLSKA S.A.reports that on 3 April 2024 the aforementioned Agreement has beencompleted. As a result thereof, the Company has become the owner of a72.22% equity stake in eZebra, while following the registration of theincrease of the share capital held by eZebra, it will hold a 75% equitystake.

eZebra runs an internet drug store at the website of ezebra.pl thatoffers a wide range of cosmetics, perfumes and accessories in thebeauty, health, personal hygiene and household categories.

The total price for the Shares is PLN 63 million (this amount is subjectto verification according to selected actual financial data as of theClosing Date), of which PLN 11.5 million has been contributed to eZebraas a contribution-in-kind to subscribe for new shares in the sharecapital of eZebra and support its ongoing development, while the amountof PLN 51.5 million constitutes payment for the secondary shares.

Pursuant to the Agreement, in reference to the remaining 25% equitystake of eZebra, the Company has been given the right to acquire it(Call Option), and the Founders have been given the right to put thatequity stake to the Company (Put Option), under the terms and on thedates described in current report No. 8/2023.

Legal basis: Art. 17 section 1 of Regulation (EU) No 596/2014 of theEuropean Parliament and of the Council on market abuse (market abuseregulation) of 16 April 2014 and repealing Directive 2003/6/EC of theEuropean Parliament and of the Council and Commission Directives2003/124/EC, 2003/125/EC and 2004/72/EC

Talk to a Data Expert

Have a question? We'll get back to you promptly.